Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the clinical efficacy of transcranial magnetic stimulation in the treatment of Depersonalization Disorder (DPD).


Clinical Trial Description

This study is a research trial of an outpatient, non-medication, non-invasive investigational treatment called Transcranial Magnetic Stimulation (TMS). TMS applies a magnetic field to the brain for a brief period of time. TMS is a procedure that involves 30 minute-long daily sessions every weekday for a series of weeks. The investigators are testing whether TMS can treat Depersonalization Disorder (DPD).

This is an open-label study. All patients will receive active treatment. DPD symptoms will be monitored through weekly self-report questionnaires as well clinical ratings with a doctor. ;


Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00529217
Study type Interventional
Source New York State Psychiatric Institute
Contact
Status Completed
Phase Phase 2
Start date May 2006
Completion date October 2010

See also
  Status Clinical Trial Phase
Recruiting NCT02256085 - Treatment of Depersonalization Disorder With Repetitive Transcranial Magnetic Stimulation (rTMS) Phase 2
Completed NCT02476435 - Depersonalization Disorder: Therapeutic Effect of Neuronavigated Repetitive Transcranial Stimulation N/A
Completed NCT00004446 - Study of Fluoxetine in Patients With Depersonalization Disorder N/A